Constance T. Albarracin
- Cancer Research top 0.5%
- Molecular Biology top 5%
- Oncology top 1%
- Pathology and Forensic Medicine top 0.5%
- Genetics top 2%
- Co-authors
- Gabriel N. HortobágyiErika ResetkovaAna M. González-AnguloBanu ArunAdriana LópezVicente ValeroNour SneigeFunda Meric‐Bernstam
- Topics
- Breast Cancer Treatment Studies (36 papers)Breast Lesions and Carcinomas (36 papers)Cancer and Skin Lesions (20 papers)
- Partner nations
- United StatesChinaUnited Arab Emirates
In The Last Decade
Constance T. Albarracin
121 papers receiving 5.1k citations
Peers
Comparison fields: 5 of 112
- Cancer Research 2.1k
- Molecular Biology 1.8k
- Oncology 1.7k
- Pathology and Forensic Medicine 1.3k
- Genetics 894
Countries citing papers authored by Constance T. Albarracin
This map shows the geographic impact of Constance T. Albarracin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Constance T. Albarracin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Constance T. Albarracin more than expected).
Fields of papers citing papers by Constance T. Albarracin
This network shows the impact of papers produced by Constance T. Albarracin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Constance T. Albarracin. The network helps show where Constance T. Albarracin may publish in the future.
Co-authorship network of co-authors of Constance T. Albarracin
This figure shows the co-authorship network connecting the top 25 collaborators of Constance T. Albarracin. A scholar is included among the top collaborators of Constance T. Albarracin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Constance T. Albarracin. Constance T. Albarracin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 4 | |
| 3 | 7 | |
| 4 | 2 | |
| 5 | 18 | |
| 6 | 200 | |
| 7 | 21 | |
| 8 | 10 | |
| 9 | 50 | |
| 10 | 7 | |
| 11 | 15 | |
| 12 | 21 | |
| 13 | 123 | |
| 14 | 23 | |
| 15 | 32 | |
| 16 | 81 | |
| 17 | 71 | |
| 18 | 3 | |
| 19 | 44 | |
| 20 | Furosemide unveils hidden tubule dysfunction induced by a short term treatment with cyclosporin A in isogenic minipigs | 2 |
About Constance T. Albarracin
Constance T. Albarracin is a scholar working on Cancer Research, Dermatology and Pathology and Forensic Medicine, having authored 122 papers that have together received 5.2k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (36 papers), Breast Lesions and Carcinomas (36 papers) and Cancer and Skin Lesions (20 papers). The work is most often cited by research in Cancer Research (2.1k citations), Pathology and Forensic Medicine (1.3k citations) and Oncology (1.7k citations). Constance T. Albarracin has collaborated with scholars based in United States, China and United Arab Emirates. Frequent co-authors include Gabriel N. Hortobágyi, Erika Resetkova, Ana M. González-Angulo, Banu Arun, Adriana López, Vicente Valero, Nour Sneige, Funda Meric‐Bernstam, Christopher I. Amos and Geula Gibori. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.